FTIOP
GILD icon

Fiduciary Trust International of Pennsylvania’s Gilead Sciences GILD Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$913K Buy
12,208
+291
+2% +$20.1K 0.04% 221
2019
Q4 		$774K Sell
11,917
-1,250
-9% -$81.4K 0.03% 229
2019
Q3 		$834K Sell
13,167
-868
-6% -$56.7K 0.03% 251
2019
Q2 		$948K Sell
14,035
-1,126
-7% -$74.1K 0.04% 242
2019
Q1 		$985K Sell
15,161
-3,400
-18% -$226K 0.04% 212
2018
Q4 		$1.16M Sell
18,561
-8,700
-32% -$608K 0.06% 194
2018
Q3 		$2.1M Sell
27,261
-67,970
-71% -$5.13M 0.09% 178
2018
Q2 		$6.75M Sell
95,231
-5,607
-6% -$396K 0.3% 85
2018
Q1 		$7.6M Sell
100,838
-4,720
-4% -$375K 0.35% 85
2017
Q4 		$7.56M Sell
105,558
-3,017
-3% -$229K 0.34% 91
2017
Q3 		$8.8M Sell
108,575
-43,676
-29% -$3.34M 0.42% 73
2017
Q2 		$10.8M Buy
152,251
+72,915
+92% +$4.85M 0.53% 62
2017
Q1 		$5.39M Sell
79,336
-916
-1% -$64.4K 0.41% 75
2016
Q4 		$5.75M Sell
80,252
-16,066
-17% -$1.19M 0.46% 67
2016
Q3 		$7.62M Sell
96,318
-8,443
-8% -$686K 0.61% 52
2016
Q2 		$8.74M Buy
104,761
+905
+0.9% +$80.3K 0.71% 41
2016
Q1 		$9.54M Sell
103,856
-44,066
-30% -$3.97M 0.81% 39
2015
Q4 		$15M Buy
147,922
+495
+0.3% +$51.5K 1.28% 23
2015
Q3 		$14.5M Sell
147,427
-61,838
-30% -$6.87M 1.35% 20
2015
Q2 		$24.5M Buy
209,265
+81,999
+64% +$8.96M 1.45% 10
2015
Q1 		$12.5M Buy
127,266
+37,246
+41% +$3.78M 0.81% 36
2014
Q4 		$8.48M Sell
90,020
-27,074
-23% -$2.8M 0.56% 53
2014
Q3 		$12.5M Buy
117,094
+10,647
+10% +$1.04M 0.86% 37
2014
Q2 		$8.83M Buy
106,447
+32,770
+44% +$2.55M 0.61% 51
2014
Q1 		$5.22M Buy
73,677
+2,660
+4% +$209K 0.38% 75
2013
Q4 		$5.33M Buy
71,017
+31,680
+81% +$2.21M 0.4% 72
2013
Q3 		$2.47M Buy
39,337
+17,255
+78% +$1.03M 0.2% 133
2013
Q2 		$1.13M Buy
+22,082
New +$1.15M 0.1% 168

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's GILD Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania increased its Gilead Sciences (GILD) stake by 2.4% in Q1 2020, buying an estimated $20.1K and bringing the position to 12,208 shares worth $913K. The position accounts for 0.04% of the portfolio, ranked #221.

Fiduciary Trust International of Pennsylvania first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $24.5M in Q2 2015. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Fiduciary Trust International of Pennsylvania held 12,208 shares of Gilead Sciences worth $913K as of Q1 2020.
  • Fiduciary Trust International of Pennsylvania bought 291 Gilead Sciences shares in Q1 2020, an estimated $20.1K.
  • Gilead Sciences made up 0.04% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #221 holding.
  • Fiduciary Trust International of Pennsylvania first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
  • Fiduciary Trust International of Pennsylvania's Gilead Sciences position peaked at $24.5M in Q2 2015.
  • 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.